Skip to main content

Table 2 Clinical and background variables of each eGFR category

From: Prevalence and risk factors of chronic kidney disease among Palestinian type 2 diabetic patients: a cross-sectional study

eGFR Stage
(n)
5: GFR ≥ 90
(n = 127)
4: GFR = 60–89
(n = 168)
3: GFR = 30–59
(n = 76)
2: GFR = 15–29(n = 10) 1: GFR < 15
(n = 5)
P value*
Age (years) 53.1 ± 9.4 63.2 ± 8.9 67.2 ± 7.3 62.1 ± 9.8 65 ± 12.5 < 0.001
Systolic BP (mmHg) 133 ± 16.5 139.3 ± 17.7 139.2 ± 19.9 153 ± 15.6 154 ± 22 < 0.001
Diastolic BP (mmHg) 77.7 ± 11.4 76.5 ± 11.2 77.5 ± 10.5 80.1 ± 14 81.4 ± 6.8 0.883
Hypertension Duration (years) 6.5 ± 5 9.0 ± 7.4 11.0 ± 9 11.6 ± 13.3 12.6 ± 6.8 0.013
HbA1c (%) 8.58 ± 2 8.38 ± 1.98 8.57 ± 2.2 7.3 ± 1.7 6.4 ± 1.14 0.057
Diabetes Duration (years) 9.3 ± 6.6 12.9 ± 8.4 14.9 ± 8.8 16.8 ± 13.2 21.4 ± 9.8 0.007
  1. *Kruskal Wallis test, BP Blood Pressure, eGFR Estimated glomerular filtration rate